Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$599,140
+$295,473 QoQ
Shares Held
3,823
+92.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#813
of 1,602 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Verity Asset Management, Inc. holds $13,024,966 across 11 Drug Manufacturers - General names. NVS ranks #9 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
8,729 | $3,160,945 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
31,404 | $1,809,498 | |
| 3 | JNJ |
Johnson & Johnson
|
5,968 | $1,515,692 | |
| 4 | GSK |
GSK plc
|
25,025 | $1,311,810 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
10,134 | $1,280,329 | |
| 6 | MRK |
Merck & Co., Inc.
|
8,942 | $1,149,047 | |
| 7 | LLY |
ELI LILLY & Co
|
569 | $682,475 | |
| 8 | ABBV |
AbbVie Inc.
|
2,707 | $681,189 |
All Filings in NVS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $599,140 | 3,823 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $303,667 | 1,988 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $276,980 | 2,009 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $323,293 | 2,521 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $517,922 | 4,280 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $477,914 | 4,287 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $417,167 | 4,287 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $430,634 | 3,744 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $402,951 | 3,785 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $375,505 | 3,882 | Shares | Sole | 2024-05-28 | |
| 2023-12-31 | $385,907 | 3,822 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $323,609 | 3,177 | Shares | Sole | 2023-11-22 | |
| 2023-06-30 | $216,653 | 2,147 | Shares | Sole | 2023-08-16 | |
| 2023-03-31 | $207,644 | 2,257 | Shares | Sole | 2023-05-24 | |
| 2022-12-31 | $217,002 | 2,392 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||